A New Hope for Cervical Cancer Patients: EU Approves TIVDAK

EU grants approval for TIVDAK, the first ADC for advanced cervical cancer, offering new hope to patients.

Mrudula Kulkarni | Apr 01, 2025

AI in Pharma

LIXTE And NKI Launch Pre-Clinical Study To Target Early Cancer Cells With LB-100

LIXTE & NKI launch a study on LB-100’s potential to eliminate pre-cancerous cells and prevent cancer.

Simantini Singh Deo | Apr 01, 2025

Teva Unveils Promising TEV-'749 Schizophrenia Treatment Data at SIRS 2025

Survey reveals high satisfaction with TEV-'749 in schizophrenia treatment, supporting its potential as a long-acting option.

Mrudula Kulkarni | Apr 01, 2025

AI in Pharma

Nxera Pharma Welcomes New Leadership to Drive Global Growth

Nxera Pharma appoints Kiyoshi Kaneko as CCO and Mariko Nakafuji as CLO, strengthening its leadership team.

Mrudula Kulkarni | Apr 01, 2025

Ascendis Pharma Seeks FDA Approval for Transformative Achondroplasia Treatment

Ascendis Pharma submits FDA application for TransCon CNP, a potential breakthrough for children with achondroplasia.

Mrudula Kulkarni | Apr 01, 2025

Merck’s WINREVAIR™ Achieves Breakthrough in PAH Treatment, Cutting Mortality Risk by 76%

WINREVAIR™ trial shows 76% reduced risk of PAH mortality & hospitalization, marking a major advance in treatment.

Mrudula Kulkarni | Apr 01, 2025

Kenan Thompson Teams Up with Phathom to Tackle GERD—With a Side of Comedy

Kenan Thompson partners with Phathom to raise GERD awareness, sharing his journey with heartburn relief.

Mrudula Kulkarni | Mar 31, 2025